United States· US:84545-250_5c0c36c2-0dcf-4762-8653-31805880f668
Avance Nerve Graft
A medicinal product containing human peripheral nerve tissue, registered in United States by Axogen Corporation.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HUMAN PERIPHERAL NERVE TISSUE
- Manufacturer
- Axogen Corporation
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1184545250011 CARTON in 1 BAG (84545-250-01) / 1 POUCH in 1 CARTON / 1 POUCH in 1 POUCH / 1 CONTAINER in 1 POUCH / 1 mm in 1 CONTAINER
- ndc1184545-250-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bbfeb08f-efaa-4072-b8f1-b65107590918 GET /v1/drugs/bbfeb08f-efaa-4072-b8f1-b65107590918?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SOFT TISSUE",
"source": "ndc",
"strength": "2",
"substance": "HUMAN PERIPHERAL NERVE TISSUE",
"productndc": "84545-250",
"dosage_form": "IMPLANT",
"dea_schedule": null,
"strength_unit": "mm/50mm",
"application_number": "BLA125816",
"marketing_category": "BLA"
}See everything about human peripheral nerve tissue.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.